The novel therapy of the medication represents a major advance in the management of the condition. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide886982.bligblogging.com/42806119/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment